Adam J. Khorasanchi

Internal Medicine

101 Nicolls Rd
Stony Brook, NY 11794

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitors.

Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitors.

Journal: Journal of Cancer

Published: December 16, 2025

Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy.

Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 07, 2025

Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer.

Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer.

Journal: Current treatment options in oncology

Published: July 13, 2025

Novel Immunotherapeutic Approaches for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma.

Novel Immunotherapeutic Approaches for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma.

Journal: Oncology research

Published: June 11, 2025

Race and Outcomes to [177Lu]Lu-PSMA-617 in Advanced Prostate Cancer.

Race and Outcomes to [177Lu]Lu-PSMA-617 in Advanced Prostate Cancer.

Journal: Cancers

Published: April 29, 2025

CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression.

CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2025

CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches.

CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 28, 2025

Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based Therapies.

Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based Therapies.

Journal: Cancer medicine

Published: February 26, 2025

Perioperative therapies for metastatic renal cell carcinoma.

Perioperative therapies for metastatic renal cell carcinoma.

Journal: Journal of cancer metastasis and treatment

Published: January 01, 2025

Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches.

Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: November 05, 2024

Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies.

Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies.

Journal: Cancers

Published: October 08, 2024

Perioperative systemic therapy in high-risk renal cell carcinoma following nephrectomy: a narrative review.

Perioperative systemic therapy in high-risk renal cell carcinoma following nephrectomy: a narrative review.

Journal: Translational cancer research

Published: January 05, 2024

Showing 1-12 of 22

Last Updated: 09/26/2026